Evidence map›Paper›PMID 35349039›Full record

ArticleMolecular imaging and biology2022

Head-to-head Intra-individual Comparison of [

E Novruzov, K Dendl, H Ndlovu, P L Choyke, M Dabir, M Beu, F Novruzov, E Mehdi, F Guliyev, S A Koerber and 6 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Comparison ofFrontiers in oncology · 2023
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Potential value of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. European journal of nuclear medicine and molecular imaging · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Is There a Role for FAPI PET in Urological Cancers?Molecular diagnosis & therapy · 2024
    Review
  19. Efficacy ofJapanese journal of radiology · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 4 countries.

E NovruzovDepartment of Nuclear Medicine, Medical Faculty, Heinrich-Heine-University, University Hospital Dusseldorf, Dusseldorf, Germany.
K DendlDepartment of Nuclear Medicine, Medical Faculty, Heinrich-Heine-University, University Hospital Dusseldorf, Dusseldorf, Germany.
H NdlovuDepartment of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa.
P L ChoykeMolecular Imaging Branch, National Cancer Institute, Bethesda, MD, USA.
M DabirDepartment of Nuclear Medicine, Medical Faculty, Heinrich-Heine-University, University Hospital Dusseldorf, Dusseldorf, Germany.
M BeuDepartment of Nuclear Medicine, Medical Faculty, Heinrich-Heine-University, University Hospital Dusseldorf, Dusseldorf, Germany.
F NovruzovNuclear Medicine Department, National Centre of Oncology, Baku, Azerbaijan.
E MehdiNuclear Medicine Department, National Centre of Oncology, Baku, Azerbaijan.
F GuliyevDepartment of Uro-Oncology, National Centre of Oncology, Baku, Azerbaijan.
S A KoerberDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
I LawalMolecular Imaging Branch, National Cancer Institute, Bethesda, MD, USA.
G NiegischDepartment of Urology, University Hospital Duesseldorf, Duesseldorf, Germany.
J DebusDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
U HaberkornDepartment of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
M SathekgeDepartment of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa.
F L GieselDepartment of Nuclear Medicine, Medical Faculty, Heinrich-Heine-University, University Hospital Dusseldorf, Dusseldorf, Germany. frederik@egiesel.com.
Heinrich Heine University Düsseldorf · DEDüsseldorf University Hospital · DEHeidelberg University · DENational Cancer Institute · USNational Nuclear Research Center · AZUniversity Hospital Heidelberg · DESteve Biko Hospital · ZAUniversity of Pretoria · ZAVA Fanarjian National Center of Oncology · AZ

Funding

Growth Factor Imaging and PhotoimmunotherapyZIABC010656 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2024
$31.6M
6 · The paper itself

Abstract

aim/purposeFibroblast activation protein-(FAP)-ligands, a novel class of tracers for PET/CT imaging, demonstrated promising results in previous studies in various malignancies compared to standard [ MATERIAL AND

methodsThis retrospective analysis consisted of 8 patients (median age 66), 7 of whom underwent both [

resultsOverall, 31 metastases were detected in five patients including lymph node metastases (n = 23), bone metastases (n = 4), lung metastases (n = 3), and a peritoneal metastasis (n = 1). In one patient, [

conclusion[

Indexed as

Positron Emission Tomography Computed TomographyUrinary Bladder NeoplasmsAgedFluorodeoxyglucose F18Gallium RadioisotopesHumansProspective StudiesRetrospective StudiesFluorodeoxyglucose F18Gallium RadioisotopesBladder cancerFAPIFibroblast activation proteinPETUrothelial carcinoma

Identifiers

PMID35349039
PMCPMC9296390
OpenAlexW4220943328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.